Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 17  •  04:00PM ET
0.6686
Dollar change
+0.0096
Percentage change
1.46
%
Index
-
P/E
-
EPS (ttm)
-0.75
Insider Own
53.39%
Shs Outstand
40.52M
Perf Week
3.51%
Market Cap
27.09M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
18.89M
Perf Month
16.06%
Enterprise Value
30.34M
PEG
-
EPS next Q
-
Inst Own
0.07%
Perf Quarter
-47.35%
Income
-3.19M
P/S
6.54
EPS this Y
-
Inst Trans
-6.48%
Perf Half Y
-64.81%
Sales
4.14M
P/B
0.45
EPS next Y
-
ROA
-13.78%
Perf YTD
-44.74%
Book/sh
1.48
P/C
77.40
EPS next 5Y
-
ROE
-20.67%
52W High
2.60 -74.26%
Perf Year
-55.33%
Cash/sh
0.01
P/FCF
301.00
EPS past 3/5Y
73.01% 53.14%
ROIC
-13.84%
52W Low
0.50 33.64%
Perf 3Y
-96.81%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-20.03% -17.53%
Gross Margin
-23.73%
Volatility
7.56% 9.94%
Perf 5Y
-99.80%
Dividend TTM
-
EV/Sales
7.33
EPS Y/Y TTM
72.59%
Oper. Margin
-78.16%
ATR (14)
0.06
Perf 10Y
-99.39%
Dividend Ex-Date
-
Quick Ratio
0.10
Sales Y/Y TTM
-8.49%
Profit Margin
-76.91%
RSI (14)
54.42
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.32
EPS Q/Q
61.71%
SMA20
6.39%
Beta
1.16
Target Price
-
Payout
-
Debt/Eq
0.16
Sales Q/Q
8.11%
SMA50
7.95%
Rel Volume
2.50
Prev Close
0.66
Employees
221
LT Debt/Eq
0.00
Earnings
-
SMA200
-50.80%
Avg Volume
45.26K
Price
0.67
IPO
Apr 17, 2002
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
110,581
Change
1.46%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
Apr-04-25 04:05PM
Dec-18-24 08:30AM
Dec-13-24 08:00AM
Aug-19-24 08:00AM
Feb-23-24 04:05PM
08:00AM Loading…
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
Oct-01-22 10:05PM
Jul-18-22 08:00AM
05:00PM Loading…
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
Aug-11-20 10:10AM
Jun-04-20 07:59PM
06:30AM Loading…
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
07:10AM
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
06:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
06:00AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
Apr-05-16 11:33AM
10:27AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.